Exact Mass: 470.163548

Exact Mass Matches: 470.163548

Found 149 metabolites which its exact mass value is equals to given mass value 470.163548, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

7-hydroxymethotrexate

(2S)-2-[(4-{[(4-amino-2-imino-7-oxo-1,2,3,7-tetrahydropteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic acid

C20H22N8O6 (470.1662232)


7-hydroxymethotrexate is a metabolite of methotrexate. Methotrexate, abbreviated MTX and formerly known as amethopterin, is an antimetabolite and antifolate drug. It is used in treatment of cancer, autoimmune diseases, ectopic pregnancy, and for the induction of medical abortions. It acts by inhibiting the metabolism of folic acid. Methotrexate began to replace the more toxic antifolate aminopterin starting in the 1950s. The drug was developed by Yellapragada Subbarao. (Wikipedia) D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists

   

3-Carboxylic acid-picumast

7-(3-{4-[(4-chlorophenyl)methyl]piperazin-1-yl}propoxy)-4-methyl-2-oxo-2H-chromene-3-carboxylic acid

C25H27ClN2O5 (470.16084020000005)


   

Docarpamine

5-{2-[2-acetamido-4-(methylsulfanyl)butanamido]ethyl}-2-[(ethoxycarbonyl)oxy]phenyl ethyl carbonate

C21H30N2O8S (470.172278)


   

Marchantin E

Marchantin E

C29H26O6 (470.17292960000003)


CONFIDENCE Predicted

   

Alvaradoin M

Alvaradoin M

C25H26O9 (470.15767460000006)


A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a 3-O-senecioyl-alpha-L-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10S stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.

   
   

Alvaradoin L

Alvaradoin L

C25H26O9 (470.15767460000006)


A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a 2-O-senecioyl-alpha-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10S stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.

   
   

11,12-(Methylenedioxy)kopsaporine

11,12-(Methylenedioxy)kopsaporine

C24H26N2O8 (470.1689076)


   
   
   

2-(1,3-Benzodioxol-5-yl)-3,5,6,8-tetramethoxy-7-[(3-methyl-2-butenyl)oxy]-4H-1-benzopyran-4-one

2-(1,3-Benzodioxol-5-yl)-3,5,6,8-tetramethoxy-7-[(3-methyl-2-butenyl)oxy]-4H-1-benzopyran-4-one

C25H26O9 (470.15767460000006)


   
   
   
   
   
   
   
   
   

(2alpha,3alpha,4beta,5alpha,12R,19alpha)-6,7-didehydro-3,4-dihydroxy-17-methoxy-8-oxo-2,21-cycloaspidospermidine-1,3-dicarboxylic acid dimethyl ester|3-oxo-kopsingine|kopsidarine

(2alpha,3alpha,4beta,5alpha,12R,19alpha)-6,7-didehydro-3,4-dihydroxy-17-methoxy-8-oxo-2,21-cycloaspidospermidine-1,3-dicarboxylic acid dimethyl ester|3-oxo-kopsingine|kopsidarine

C24H26N2O8 (470.1689076)


   

5-[4-[2-(3-Hydroxyphenyl)ethyl]phenoxy]-6-methoxy-9,10-dihydrophenanthrene-1,2,7-triol

5-[4-[2-(3-Hydroxyphenyl)ethyl]phenoxy]-6-methoxy-9,10-dihydrophenanthrene-1,2,7-triol

C29H26O6 (470.17292960000003)


   

7-Hydroxymethotrexat

2-[[4-[(2,4-diamino-7-oxo-8H-pteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid

C20H22N8O6 (470.1662232)


D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists CONFIDENCE standard compound; INTERNAL_ID 2731 CONFIDENCE standard compound; INTERNAL_ID 8505

   

Ala Cys Phe Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanoic acid

C20H30N4O5S2 (470.165753)


   

Ala Cys Met Phe

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Ala Phe Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C20H30N4O5S2 (470.165753)


   

Ala Phe Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Ala Met Cys Phe

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Ala Met Phe Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Ala Phe Met

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Ala Met Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Cys Phe Val

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Cys Val Phe

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Asp His Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carboxypropanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidine-2-carboxylic acid

C18H26N6O7S (470.15836060000004)


   

Cys Asp Pro His

(3S)-3-[(2R)-2-amino-3-sulfanylpropanamido]-4-[(2S)-2-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C18H26N6O7S (470.15836060000004)


   

Cys Phe Ala Met

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]propanamido]-4-(methylsulfanyl)butanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Phe Cys Val

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]-3-methylbutanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Phe Met Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]propanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Phe Val Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Cys His Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C18H26N6O7S (470.15836060000004)


   

Cys His Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C18H26N6O7S (470.15836060000004)


   

Cys Met Ala Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]propanamido]-3-phenylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Met Phe Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]propanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Pro Asp His

(3S)-3-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}propanoic acid

C18H26N6O7S (470.15836060000004)


   

Cys Pro His Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanamido]butanedioic acid

C18H26N6O7S (470.15836060000004)


   

Cys Val Cys Phe

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylbutanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Cys Val Phe Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Asp Cys His Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidine-2-carboxylic acid

C18H26N6O7S (470.15836060000004)


   

Asp Cys Pro His

(3S)-3-amino-3-{[(2R)-1-[(2S)-2-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}pyrrolidin-1-yl]-1-oxo-3-sulfanylpropan-2-yl]carbamoyl}propanoic acid

C18H26N6O7S (470.15836060000004)


   

Asp His Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C18H26N6O7S (470.15836060000004)


   

Asp His Pro Cys

(3S)-3-amino-3-{[(2S)-1-[(2S)-2-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}pyrrolidin-1-yl]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]carbamoyl}propanoic acid

C18H26N6O7S (470.15836060000004)


   

Asp Pro Cys His

(3S)-3-amino-4-[(2S)-2-{[(1R)-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C18H26N6O7S (470.15836060000004)


   

Asp Pro His Cys

(3S)-3-amino-4-[(2S)-2-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C18H26N6O7S (470.15836060000004)


   

Asp Ser Ser Tyr

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propanoic acid

C19H26N4O10 (470.16488560000005)


   

Asp Ser Tyr Ser

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propanoic acid

C19H26N4O10 (470.16488560000005)


   

Asp Tyr Ser Ser

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}propanoic acid

C19H26N4O10 (470.16488560000005)


   

Phe Ala Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C20H30N4O5S2 (470.165753)


   

Phe Ala Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Phe Cys Ala Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]propanamido]-4-(methylsulfanyl)butanoic acid

C20H30N4O5S2 (470.165753)


   

Phe Cys Cys Val

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-methylbutanoic acid

C20H30N4O5S2 (470.165753)


   

Phe Cys Met Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]propanoic acid

C20H30N4O5S2 (470.165753)


   

Phe Cys Val Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-3-methylbutanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Phe Met Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]propanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Phe Met Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]propanoic acid

C20H30N4O5S2 (470.165753)


   

Phe Val Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

His Cys Asp Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C18H26N6O7S (470.15836060000004)


   

His Cys Pro Asp

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C18H26N6O7S (470.15836060000004)


   

His Asp Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carboxypropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C18H26N6O7S (470.15836060000004)


   

His Asp Pro Cys

(3S)-3-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-[(2S)-2-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C18H26N6O7S (470.15836060000004)


   

His Pro Cys Asp

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]butanedioic acid

C18H26N6O7S (470.15836060000004)


   

His Pro Asp Cys

(3S)-3-{[(2S)-1-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C18H26N6O7S (470.15836060000004)


   

Met Ala Cys Phe

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]propanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Met Ala Phe Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]propanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Met Cys Ala Phe

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]propanamido]-3-phenylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Met Cys Phe Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]propanoic acid

C20H30N4O5S2 (470.165753)


   

Met Phe Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]propanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Met Phe Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]propanoic acid

C20H30N4O5S2 (470.165753)


   

Pro Cys Asp His

(3S)-3-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-3-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanoic acid

C18H26N6O7S (470.15836060000004)


   

Pro Cys His Asp

(2S)-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanamido]butanedioic acid

C18H26N6O7S (470.15836060000004)


   

Pro Asp Cys His

(3S)-3-{[(1R)-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C18H26N6O7S (470.15836060000004)


   

Pro Asp His Cys

(3S)-3-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C18H26N6O7S (470.15836060000004)


   

Pro His Cys Asp

(2S)-2-[(2R)-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-sulfanylpropanamido]butanedioic acid

C18H26N6O7S (470.15836060000004)


   

Pro His Asp Cys

(3S)-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-3-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanoic acid

C18H26N6O7S (470.15836060000004)


   

Ser Asp Ser Tyr

(3S)-3-[(2S)-2-amino-3-hydroxypropanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propanoic acid

C19H26N4O10 (470.16488560000005)


   

Ser Asp Tyr Ser

(3S)-3-[(2S)-2-amino-3-hydroxypropanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}propanoic acid

C19H26N4O10 (470.16488560000005)


   

Ser Ser Asp Tyr

(3S)-3-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}propanoic acid

C19H26N4O10 (470.16488560000005)


   

Ser Ser Tyr Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-(4-hydroxyphenyl)propanamido]butanedioic acid

C19H26N4O10 (470.16488560000005)


   

Ser Tyr Asp Ser

(3S)-3-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(4-hydroxyphenyl)propanamido]-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C19H26N4O10 (470.16488560000005)


   

Ser Tyr Ser Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(4-hydroxyphenyl)propanamido]-3-hydroxypropanamido]butanedioic acid

C19H26N4O10 (470.16488560000005)


   

Val Cys Cys Phe

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-methylbutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Val Cys Phe Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-methylbutanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Val Phe Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C20H30N4O5S2 (470.165753)


   

Tyr Asp Ser Ser

(3S)-3-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propanoic acid

C19H26N4O10 (470.16488560000005)


   

Tyr Ser Asp Ser

(3S)-3-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-hydroxypropanamido]-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C19H26N4O10 (470.16488560000005)


   

Tyr Ser Ser Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]butanedioic acid

C19H26N4O10 (470.16488560000005)


   

7-Hydroxymethotrexate

2-[[4-[(2,4-diamino-7-oxo-8H-pteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid

C20H22N8O6 (470.1662232)


D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists

   

Ethyl 4-acetoxy-5,8-bis(benzyloxy)-2-naphthoate

Ethyl 4-acetoxy-5,8-bis(benzyloxy)-2-naphthoate

C29H26O6 (470.17292960000003)


   

1-[[2-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid methyl ester

1-[[2-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid methyl ester

C26H22N4O5 (470.1590122)


   

Tamatinib

R406 (free base)

C22H23FN6O5 (470.171388)


   
   

Docarpamine

Docarpamine

C21H30N2O8S (470.172278)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

   

7-[2-(1,3-Benzothiazol-2-ylthio)ethyl]-1,3-dimethyl-8-(3-methyl-1-piperidinyl)purine-2,6-dione

7-[2-(1,3-Benzothiazol-2-ylthio)ethyl]-1,3-dimethyl-8-(3-methyl-1-piperidinyl)purine-2,6-dione

C22H26N6O2S2 (470.1558576)


   

N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine

N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine

C24H27ClN4O4 (470.17207320000006)


   

Alvaradoin K

Alvaradoin K

C25H26O9 (470.15767460000006)


A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a 2-O-senecioyl-alpha-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10R stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.

   

5-Formimidoyltetrahydrofolate(2-)

5-Formimidoyltetrahydrofolate(2-)

C20H22N8O6-2 (470.1662232)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

3-[2-(tert-butylamino)-2-oxoethoxy]-N-(4-chloro-2,5-dimethoxyphenyl)-2-naphthalenecarboxamide

3-[2-(tert-butylamino)-2-oxoethoxy]-N-(4-chloro-2,5-dimethoxyphenyl)-2-naphthalenecarboxamide

C25H27ClN2O5 (470.16084020000005)


   

4-(3,5-dimethyl-1-pyrazolyl)-N-[2-methoxy-5-(4-morpholinylsulfonyl)phenyl]benzamide

4-(3,5-dimethyl-1-pyrazolyl)-N-[2-methoxy-5-(4-morpholinylsulfonyl)phenyl]benzamide

C23H26N4O5S (470.16238260000006)


   

methyl 3-[3-[4-(3-chlorophenyl)piperazin-1-yl]propanoylamino]-4-methoxy-1H-indole-2-carboxylate

methyl 3-[3-[4-(3-chlorophenyl)piperazin-1-yl]propanoylamino]-4-methoxy-1H-indole-2-carboxylate

C24H27ClN4O4 (470.17207320000006)


   

N-[[(4S,5S)-8-(2-cyclopropylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

N-[[(4S,5S)-8-(2-cyclopropylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C21H30N2O6S2 (470.15452)


   

(3E,5R)-5-[(1R,5R,6Z,9Z,13R,15R)-5-(acetyloxy)-10-chloro-6-methyl-3-oxo-2,14-dioxabicyclo[11.2.1]hexadeca-6,9-dien-15-yl]-5-hydroxy-3-methylpent-3-enoic acid

(3E,5R)-5-[(1R,5R,6Z,9Z,13R,15R)-5-(acetyloxy)-10-chloro-6-methyl-3-oxo-2,14-dioxabicyclo[11.2.1]hexadeca-6,9-dien-15-yl]-5-hydroxy-3-methylpent-3-enoic acid

C23H31ClO8 (470.1707356)


   
   

N-[[(4S,5S)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

N-[[(4S,5S)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C21H30N2O6S2 (470.15452)


   

(6R,7S,8R)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8R)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H27FN2O4S (470.16754740000005)


   

(6R,7R,8S)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8S)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H27FN2O4S (470.16754740000005)


   

N-[[(4R,5S)-8-(2-cyclopropylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

N-[[(4R,5S)-8-(2-cyclopropylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C21H30N2O6S2 (470.15452)


   

N-[[(4R,5R)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

N-[[(4R,5R)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C21H30N2O6S2 (470.15452)


   

N-[[(4R,5S)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

N-[[(4R,5S)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C21H30N2O6S2 (470.15452)


   

N-[[(4S,5R)-8-(2-cyclopropylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

N-[[(4S,5R)-8-(2-cyclopropylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C21H30N2O6S2 (470.15452)


   

N-[[(4R,5R)-8-(2-cyclopropylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

N-[[(4R,5R)-8-(2-cyclopropylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C21H30N2O6S2 (470.15452)


   

N-[[(4S,5R)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

N-[[(4S,5R)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C21H30N2O6S2 (470.15452)


   

(6S,7S,8S)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8S)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H27FN2O4S (470.16754740000005)


   

(6R,7R,8R)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8R)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H27FN2O4S (470.16754740000005)


   

(6R,7S,8S)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8S)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H27FN2O4S (470.16754740000005)


   

(6S,7R,8S)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8S)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H27FN2O4S (470.16754740000005)


   

(6S,7R,8R)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8R)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H27FN2O4S (470.16754740000005)


   

(6S,7S,8R)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8R)-4-(3-fluorophenyl)sulfonyl-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H27FN2O4S (470.16754740000005)


   

5-Formimidoyltetrahydrofolate(2-)

5-Formimidoyltetrahydrofolate(2-)

C20H22N8O6 (470.1662232)


Dianion of 5-formimidoyltetrahydrofolic acid arising from deprotonation of both carboxylic acid functions.

   

FR177391

FR177391

C23H31ClO8 (470.1707356)


A 14-membered macrolide isolated from the Serratia liquefaciens and exhibits anti-hyperlipidemic activity.

   
   
   
   

AZD1283

AZD1283

C23H26N4O5S (470.16238260000006)


AZD1283 is a potent P2Y12 receptor antagonist with a binding IC50 of 11 nM and a GTPγS IC50 of 25 nM. AZD1283 has excellent antiplatelet aggregation potency. AZD1283 can be used to research thromboembolic disorders[1][2].

   

SF-22

SF-22

C28H26N2O3S (470.1664046000001)


SF-22 is a potent and brain-penetrant antagonist of neuropeptide Y receptor (Y2R), with the IC50 value of 750 nM. SF-22 plays an important role in neurological disease[1].